14 results
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
is expected to close on or about January 30, 2024, subject to the satisfaction of customary closing conditions.
H.C. Wainwright & Co., LLC is acting … and satisfaction of customary closing conditions related to the public offering as well as those set forth in the Company’s latest Annual Report on Form 10-K
8-K
EX-4.2
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale
8-K
EX-4.1
jriz2uat
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-4.3
ww75m
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-10.1
3d2584pvdik7
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
906u5540
29 Jan 24
Prospectus supplement with pricing info
4:15pm
- Prev
- 1
- Next